J Vantelon

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 101 citations · Full text

Gastrointestinal Oncology, Medicine, Pathology +8

A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment

T. Girinsky, Dolores Guillot-Vals, Serge Koscielny et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 68 citations

Adaptive Radiotherapy, Lymphoid Neoplasia, Low-dose Radiation +11

Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.

Christian Verger, O Brunschvicg, Le Charpentier Y et al. · PubMed · 1981 · 61 citations

Higher Permeability, Dialysis, Membrane Characterization +17

High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)

Elias Jabbour, Serge Koscielny, Catherine Sebban et al. · Leukemia · 2006 · 41 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +11

A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody

Dany Gholam, J Vantelon, Ahmad Aljijakli et al. · Annals of Hematology · 2003 · 39 citations

Alzheimer's Disease, Autoimmune Disease, Immunology +6